Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2522 participants
INTERVENTIONAL
2024-01-18
2024-01-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impacts of Alcohol Warning Labels: An Online Experiment
NCT06442800
Impact of Alcohol Labels in a Real-World Setting
NCT06915298
Motivations, Attitudes, and Perceptions Study
NCT05873413
Personalized Booster Feedback After Alcohol Health Education
NCT03440476
Timing Personalized Feedback After Alcohol Health Education
NCT04453007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Alcohol Messages
Participants view 12 messages: 10 messages related to health topics (2 messages for each of 5 randomly selected health topics from among all health topics) and 2 control messages.
Mouth cancer warning
Participants will view messages about the risk of mouth cancer from alcohol consumption.
Throat cancer warning
Participants will view messages about the risk of throat cancer from alcohol consumption.
Voice box (larynx) warning
Participants will view messages about the risk of voice box (larynx) cancer from alcohol consumption.
Esophagus cancer warning
Participants will view messages about the risk of esophagus cancer from alcohol consumption.
Liver cancer warning
Participants will view messages about the risk of liver cancer from alcohol consumption.
Colon and rectum cancer warning
Participants will view messages about the risk of colon and rectum cancer from alcohol consumption.
Breast cancer
Participants will view messages about the risk of breast cancer from alcohol consumption.
Cancer (generic, not site-specific)
Participants will view messages about the risk of cancer (not site-specific) from alcohol consumption.
Addiction and neurological changes
Participants will view messages about the risk of addiction and neurological changes from alcohol consumption.
Hypertension
Participants will view messages about the risk of hypertension from alcohol consumption.
Liver damage
Participants will view messages about the risk of liver damage from alcohol consumption.
Harm to fetus
Participants will view messages about the risk of harm to a fetus from alcohol consumption during pregnancy.
Dementia
Participants will view messages about the risk of dementia from alcohol consumption.
Impaired sleep
Participants will view messages about the risk of impaired sleep from alcohol consumption.
Drinking guidelines
Participants will view messages about guidelines for alcohol consumption.
Control
Participants will view neutral messages unrelated to the harms of alcohol consumption.
Road injuries
Participants will view messages about the risk of road injuries from alcohol consumption.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mouth cancer warning
Participants will view messages about the risk of mouth cancer from alcohol consumption.
Throat cancer warning
Participants will view messages about the risk of throat cancer from alcohol consumption.
Voice box (larynx) warning
Participants will view messages about the risk of voice box (larynx) cancer from alcohol consumption.
Esophagus cancer warning
Participants will view messages about the risk of esophagus cancer from alcohol consumption.
Liver cancer warning
Participants will view messages about the risk of liver cancer from alcohol consumption.
Colon and rectum cancer warning
Participants will view messages about the risk of colon and rectum cancer from alcohol consumption.
Breast cancer
Participants will view messages about the risk of breast cancer from alcohol consumption.
Cancer (generic, not site-specific)
Participants will view messages about the risk of cancer (not site-specific) from alcohol consumption.
Addiction and neurological changes
Participants will view messages about the risk of addiction and neurological changes from alcohol consumption.
Hypertension
Participants will view messages about the risk of hypertension from alcohol consumption.
Liver damage
Participants will view messages about the risk of liver damage from alcohol consumption.
Harm to fetus
Participants will view messages about the risk of harm to a fetus from alcohol consumption during pregnancy.
Dementia
Participants will view messages about the risk of dementia from alcohol consumption.
Impaired sleep
Participants will view messages about the risk of impaired sleep from alcohol consumption.
Drinking guidelines
Participants will view messages about guidelines for alcohol consumption.
Control
Participants will view neutral messages unrelated to the harms of alcohol consumption.
Road injuries
Participants will view messages about the risk of road injuries from alcohol consumption.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reside in the United States
* Able to complete a survey in English
Exclusion Criteria
* Reside outside the United States
* Unable to complete a survey in English
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Grummon
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Grummon, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Online study
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
71682
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.